'Changing the webinar delivery landscape for a better ROI'

Partners

Webinars

Key Benefits

Engage with Influencers and
Decision Makers

Quickly and efficiently engage with influencers, internal champions, and decision-makers through a variety of digital marketing channels. Our strategic approach ensures that your message reaches the right people at the right time, driving impactful results for your pharmaceutical business.

Tailored Solutions within
Your Budget

We understand the importance of working within your timelines and budgets. At Pharma D-mand, we provide tailored solutions that deliver the highest value and best practices for your marketing efforts. Our experienced team collaborates closely with you to ensure that your resources are utilized effectively, helping you achieve your goals efficiently.

Access to a Targeted
Global Audience

Partnering with Pharma D-mand gives you access to a global audience that aligns perfectly with your objectives. We utilize data-driven targeting techniques to connect you with key stakeholders and decision-makers across the pharmaceutical industry, expanding your reach and maximizing your opportunities for success.

Engaging Content for
Your Audience

Delivering content that interests and engages with your specific job title or function remit is our expertise. We craft compelling messages and engaging campaigns that resonate with your target audience. Whether you are targeting healthcare professionals, researchers, or executives, we create content that drives meaningful connections and action.

Portfolio

Things to expect: 

Things to expect: 

Things to expect: 

Things to expect: 

Things to expect: 

How it works

Consultation

Identifying the right individual, within the right company, in the right demographic and required time frames

Multi-channel campaigns

Designed around your aims and objectives to reach your target audience for demand generation

Comprehensive Reporting

Measure your success with detailed reporting giving you the tools to demonstrate ROO

Contact Us

Dr. Greg Moakes, PHD, Executive Vice President, Business Development

Greg Moakes is Executive Vice President of Business Development for LTS Lohmann Device Technologies LTD. Greg holds a Ph.D. In Chemistry from the Georgia Institute of Technology and an MBA from Southern Methodist University. His career had been focused on drug delivery, first specializing in solid implant dosage formulations and more recently high volume subcutaneous delivery via On-body Delivery Systems.

Dr Kristian Le Vay, Expert Scientist at Coriolis Pharma

Kristian Le Vay is an Expert Scientist at Coriolis, with a focus on novel methods for the developability assessment for biologics. He is a chemist by training with a diverse research background, encompassing the biophysical characterization of complex biomolecules, and the development of advanced therapeutics and drug delivery vectors. He completed his PhD at the Bristol Centre for Functional Nanomaterials (BCFN), University of Bristol, UK, where he developed a keen interest in biophysical method development. Following this, he studied nucleic acid condensation and stability as a postdoctoral scientist at the Max Planck Institute for Biochemistry, Munich, before joining Coriolis in 2022.

Dr. Andrea Hawe, Chief Scientific Officer at Coriolis Pharma

Andrea Hawe is the Chief Scientific Officer at Coriolis. She is an expert in drug product development for biologics with a strong scientific background in protein formulation, surfactant and particle characterization, and lyophilization process technology. Andrea has published more than 40 peer-reviewed papers and book chapters.

Andrea is a pharmacist with a PhD in Pharmaceutical Technology from the LMU Munich. After her PhD, she continued her career as a postdoctoral scientist at the Leiden Academic Center for Drug Research (LACDR) in Leiden (The Netherlands). She was awarded a Veni Fellowship (NWO, The Netherlands) to develop novel approaches for aggregate analysis. She joined Coriolis from the very beginning as a member of the founding team and has been supporting the company since 2008.